Checkpoint inhibitors in metastatic epidermal growth factor receptor-mutated non-small cell lung cancer patients: where we treating the wrong cancer?

J Thorac Dis. 2017 Sep;9(9):2771-2773. doi: 10.21037/jtd.2017.08.24.

Authors

Paul Zarogoulidis¹, Vasilis Papadopoulos², Elena Maragouli², George Papatsibas², Haidong Huang³

Affiliations

¹ Pulmonary Department-Oncology Unit, "Theageneio" Anticancer Hospital, Thessaloniki, Greece.
² Oncology Department, University of Thessali, Larissa, Greece.
³ Department of Respiratory and Critical Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.

No abstract available

Publication types

Editorial
Comment